DENGIALL VACCINE TRIAL
India moves closer to dengue vaccine as final trials underwayAn Indian vaccine candidate, DengiAll, is in its final testing phase. This single-dose shot offers hope against the deadly dengue disease. ...
70% enrolment of participants for Phase III clinical trial of dengue vaccine completed: CentreIndia achieves a milestone in dengue prevention. The DengiAll vaccine trial sees 70% participant enrollment. ICMR leads the multi-center st...
Phase-3 clinical trial enrolment for India's first dengue vaccine to be completed by October: ICMRIndia's DengiAll vaccine trial is nearing completion. ICMR scientists anticipate enrolling 10,500 participants by October across 20 Indian ...
In a medical breakthrough, first phase-3 dengue vaccine trial begins in IndiaIndia started its inaugural phase 3 clinical trial for the DengiAll dengue vaccine, developed by Panacea Biotec. The trial will include 10,...
First-ever phase-three clinical trial for dengue vaccine initiated in IndiaThe Indian Council of Medical Research (ICMR) and Panacea Biotec have launched the first phase three clinical trial for an indigenous dengu...
Load More